Skip to content
Careers
Contact us
Our Company
Overview
Leadership Team
Scientific Advisory Board
Pipeline & Programs
Peripherally-acting CB1 Inverse Agonists Pipeline
Monlunabant
INV-300 Series and INV-347
INV-101
Other Possible Indications
Our Approach
Peripheral CB1r Blockade
The Endocannabinoid System
References
News & Events
FR
EN
Menu
Home
Our Company
Overview
Leadership Team
Scientific Advisory Board
Pipeline & Programs
Peripherally-acting CB1 Inverse Agonists Pipeline
Monlunabant
INV-300 Series and INV-347
INV-101
Other Possible Indications
Our Approach
Peripheral CB1r Blockade
The Endocannabinoid System
References
News & Events
1000km Challenge
Careers
Contact us
Terms and Conditions
Privacy Policy
Contact us
Contact
Contact
INVERSAGO
A Novo Nordisk company
1100 René-Lévesque Blvd West
Suite 1110
Montreal, Quebec
H3B 4N4 Canada
Loading content #4282…
Loading content #2999…